WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4301 Infant (under 12 months) mortality rate: 632
GDP / capita (US$): 9671 Child (under 5 years) mortality rate: 1142

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 18'535  17'831  17'157  16'511  15'894  10'990  7'754  5'834 
Births 922  890  858  828  799  585  429  322 
Surviving infants 875  843  812  782  753  532  370  279 
Pop. less than 5 years 3'838  3'695  3'557  3'420  3'282  2'261  1'544  1'161 
Pop. less than 15 years 9'289  8'932  8'586  8'249  7'919  5'268  3'703  2'776 
Female 15-49 years 3'843  3'698  3'561  3'434  3'315  2'378  1'759  1'330 

Number of reported case

(Click for retrospective incidence data for Niger (the))
Diphtheria 73  12  102  34 
Japanese encephalitis
Measles 1'142  1'224  272  771  372  21'319  20'463  36'811 
Mumps
Pertussis 884  983  30  5'585  3'102  8'320 
Polio* 33  32  311 
Rubella 77  19 
Rubella (CRS)
Tetanus (neonatal) 11  13  55  39 
Tetanus (total)** 45  71  75  131  146  286  220  346 
Yellow fever 20 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Niger (the))
Vaccine year result method % card seen                                                
BCG 2012  85  EPI   70  98  59  99*  71  95  35  82 
DTP1 2012  87  EPI   70  99*  98  99*  99*  99  35 
DTP3 2012  78  EPI   70  93  92  96  97  92  25  35 
DTP4         
IPV1         
HepB_BD         
HepB3 2012  78  EPI   70  93  92  96  97  92 
Hib3 2012  78  EPI   70  93  92  96  97  92 
JapEnc         
MCV1          88  92  91  94  89  27  38 
MCV2         
PCV1          43 
PCV3          13 
Pol3 2012  75  EPI   70  91  80  95  61  92  23  35 
Rota1          31 
Rota_last          19 
Rubella1         
TT2plus 2011  50  DHS/MICS   65  90  89  83  93  85  31  11 
PAB         
VAD1          43  50  58  63  53 
YFV 2012  73  EPI   70  87  88  90  69  82  10 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Niger (the))
BCG 76  37  85  53  81  50  50 
DTP1 89  87  87  86  83  46  46 
DTP3 68  67  71  75  70  34  22 
HepB3 68  67  71  75  70 
HepB_BD
Hib3 68  67  71  75  70 
MCV1 72  76  75  69  67  37  25 
MCV2
PAB 81  81  84  84  84  63  17 
PCV3 13 
Pol3 67  56  71  40  75  41  22 
Rota_last 19 
YFV 70  71  73  52  64  10 

Number of districts in the country 44  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 73
From 80 to 89% 14
From 50 to 79% 14
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +2, +6 months; No 13 years
IPV 14 weeks; Yes From June 2015
Measles 9, 16 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact, +4 weeks; +6 months; +1, +1 years; Yes Pregnant women
VitaminA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011 - 2015  2011 - 2015  2007 - 2010  2007 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 44  42  42  42  42  42  42 

System performance

Total Nº districts in country number 44  42  42  42  42  42  42 
Nº districts with DTP3 coverage >=80% number 38  38  41  38  38  40  36 
% of districts with DTP3 coverage >=80% From 0 to 100% 86  90  98  90  90  95  86 
Nº districts with measles (MCV1) coverage >=95% number 12  19  18  22  11  12 
% of districts with MCV1 coverage >=95% From 0 to 100% 27  45  43  52  26  29  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       51  13  20  20 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes    No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.